Salk researchers identified Med14, a Mediator protein that helps explain how GLP‑1 drugs can strengthen pancreatic beta cells and improve insulin release.

A Northwestern analysis tied premature menopause to roughly a 40% higher lifetime coronary heart disease risk. Doctors say menopause age should be part of routine risk screening.

Congress moved to restore SBIR/STTR authority, reopening non‑dilutive R&D grants that many New York biotech startups rely on.

A 24‑year‑old man became the first patient in Michigan to receive Lyfgenia, a one‑time gene therapy for sickle cell disease, at Children’s Hospital of Michigan.

Indianapolis‑based Eli Lilly says retatrutide met a Phase‑3 diabetes endpoint with notable A1c and double‑digit weight drops at 40 weeks, while more safety and regulatory steps remain.

New reporting shows Epstein paid consultants and used fake sites and Wikipedia edits to bury negative search results and burnish a philanthropic image.

SXSW's Emerging Tech Expo opens a free public day Wednesday at Fairmont Austin with demos from AI to XR.

A UCSF pilot found a sensing‑capable, closed‑loop brain implant reduced severe chronic pain in most participants. The therapy is promising but still experimental.

Aldeyra’s shares plunged about 70% after the FDA declined to approve reproxalap, the Lexington biotech’s lead dry‑eye candidate.

The former Post-Dispatch building on North Tucker has been refitted as a multi-tenant tech campus hosting Block, Scale AI and Cyber-Up, blending offices with cybersecurity training. Owners say the mix could help jump-start downtown hiring.

A Northwestern study finds brain immune cells’ use of fructose helps glioblastoma grow in mice, highlighting the transporter GLUT5 as a possible drug target. The findings are preclinical.

Endeavor Health is advancing a roughly $29M modernization at Edward Hospital to add operating rooms and a 10‑bed ICU, aiming to ease pressure on cardiac care. State filings and local reporting detail the scope and funding.

AI‑made war clips and recycled videos are circulating on social feeds. Local experts and fact‑checkers lay out the red flags and tools to tell what’s real.